Careful definition of distinct subsets of CD4+ T cells in patients with acute COVID-19 and delineating how cytokines and chemokines imbalance influence T cell responses during the acute phase of infection and SARS-CoV-2-specific memory maintenance in COVID-19 convalescents could reveal novel opportunities for effective COVID-19 treatment in future. The gene discussed is CD4; the disease is infection.